Royal DSM, a global science-based company active in health, nutrition and materials, has repurchased 134,338 of its own shares in the period from 31 March 2017 up to and including 6 April 2017 at an average price of €64.04. This is in accordance with the repurchase, covering existing option plans and stock dividends, announced on 13 March 2017. The consideration of this repurchase was €8.6 million.
The total number of shares repurchased under this program to date is 900,531 shares for a total consideration of €56.5 million.
For more detailed information see ‘Daily transaction details 2.9m Share Repurchase Program announced 13 Mar 2017’.
